Genetic testing in neurological diseases
Related Experiment Video
Updated: May 22, 2026

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
Published on: June 6, 2025
1Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, DZNE-German Center for Neurodegenerative Diseases, Hoppe-Seyler Str 3, 72076 Tübingen, Germany.
Abstract:
The advances in sequencing technologies and the availability of molecular testing for a rapidly increasing number of diseases are both promising and challenging. Here, we will focus on practical aspects and the usefulness of molecular diagnosis in a clinical setting. Even in the absence of therapeutic consequences, genetic testing can and should be considered for a number of reasons, including a right to know for the patient and the family, and the avoidance of further diagnostic work-up. As it will soon become possible to routinely sequence hundreds or even thousands of genes in parallel, molecular diagnosis will become increasingly important as it provides valuable information for the physician and for the affected individuals.
More Related Videos
08:22A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
Published on: December 1, 2017
05:51A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
Published on: June 15, 2011
Related Concept Videos
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Neural Regulation